Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2020Journal of Clinical MedicineOpen Access

Conversion from Standard-Release Tacrolimus to MeltDose® Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation

View Full Paper
Ask AI
Bookmark
Share

Authors

JEJohannes von EinsiedelUniversity Hospital MünsterGTGerold ThölkingHelmholtz-Institute MünsterCWChristian WilmsUniversität Hamburg

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Einsiedel et al. (2020) studied this question.

synapsesocial.com/papers/6aa44cfe57cafa2484f206cehttps://doi.org/10.3390/jcm9061654
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1END-STAGE RENAL DISEASE (ESRD) AFTER ORTHOTOPIC LIVER TRANSPLANTATION (OLTX) USING CALCINEURIN-BASED IMMUNOTHERAPY12001 · 494 citations
  2. 2Cyclosporin versus Tacrolimus as Primary Immunosuppressant After Liver Transplantation:A Meta-Analysis2006 · 264 citations
  3. 3Tacrolimus: Influence of the Posttransplant Concentration/Dose Ratio on Kidney Graft Function in a Two-Year Follow-Up2019 · 30 citations
  4. 4Calcineurin Inhibitor Nephrotoxicity2009 · 1,502 citations
  5. 5The Tacrolimus Metabolism Rate Influences Renal Function after Kidney Transplantation2014 · 110 citations